Sigma Square Capital

ABclonal Inc. is a life science research and diagnostic reagents provider based in Woburn, Massachusetts, established in 2016. The company specializes in offering a range of biological research agents and services, including next generation sequencing library preparation kits, molecular biology products, catalog antibodies, catalog proteins, ELISA kits, and tools for western blotting. Additionally, ABclonal provides peptide, antibody, and protein services. The company distributes its products through a network that spans Europe, Asia, North America, and Oceania. With a team of scientists from leading universities, ABclonal is committed to enhancing the quality of life science research through its high-quality offerings.

Waytous is a technology company based in Qingdao, China, specializing in autonomous driving solutions for the mining and construction industries. Founded in November 2014, Waytous develops a cloud-based system that integrates unmanned driving for mining trucks and collaborative operation management for excavators. The company emphasizes the creation of a comprehensive training data and research and development ecosystem to enhance the performance and quality of its intelligent vehicles. Through its innovative technology, Waytous aims to improve operational efficiency and safety in heavy-duty applications.

Developer of cloud based intelligent autonomous driving technology. The company focuses on building the training data and R&D ecosystem around the intelligent vehicles field, empowering its clients to improve the quality of their autonomous car systems. The company's mission is to build the world leading cloud based intelligent autonomous driving ecosystem.

Developer of cloud based intelligent autonomous driving technology. The company focuses on building the training data and R&D ecosystem around the intelligent vehicles field, empowering its clients to improve the quality of their autonomous car systems. The company's mission is to build the world leading cloud based intelligent autonomous driving ecosystem.

Beijing GenomePrecision Technology Co., Ltd. is a molecular diagnostic company focused on developing precision medicine tests to enhance the diagnosis and treatment of various diseases, including blood tumors, transplantation needs, and cardiovascular conditions. Established in 2015 and headquartered in Beijing, the company integrates research and development, manufacturing, distribution, and registration of its products. GenomePrecision utilizes advanced molecular technology platforms, such as real-time fluorescence quantitative PCR, Sanger sequencing, high-throughput next-generation sequencing, and capillary electrophoresis, to create a diverse range of diagnostic products. These include tests for leukemia, lymphoma, solid tumors, and pharmacogenomics, as well as tools for organ transplant monitoring and pathogen detection. The company also produces molecular diagnostic kits for targeted drug testing and auxiliary diagnosis of cervical cancer, among other applications. By focusing on clinical diagnosis and treatment requirements, GenomePrecision aims to improve patient outcomes through innovative molecular diagnostics.

Iris Integrated Retail Information Solution is a retail IT solution provider based in Shanghai, China. The company specializes in offering a range of enterprise services that include IT retail data operations, business intelligence solutions, and cloud-based management systems. Iris provides the Iris BI 1.2 Pro series, an integrated application designed for businesses engaged in retail data processing across various industries. Additionally, the company develops mobile applications and offers services in mobile IT products, including eBook production and app development. Iris also provides IT consulting and training services to support businesses in optimizing their operations and leveraging technology effectively.

Shenzhen Fanlai Technology Co., Ltd. specializes in developing innovative kitchen automation solutions and smart kitchen appliances. Based in Shenzhen, China, the company focuses on integrating intelligent automation and artificial intelligence into its products, allowing consumers to prepare homemade meals with greater ease and efficiency. By combining advanced technology with user-friendly design, Fanlai Tech aims to enhance the cooking experience in households.

Liking Fit is a Chinese franchise smart gym operator. Liking Fit is an internet and intelligent fitness innovation and development of enterprises. The company was officially established in September 2014 and is headquartered in Shanghai. Liking fitness under the Shanghai really fast Information Technology Co., Ltd., is a 24-hour intelligent Internet gym. Liking fitness with online fitness APP support, offline matching Internet smart fitness venues, truly unmanaged management, allowing users to enjoy Fitness Free mode at any time. Liking Fitness recruits City Partners nationwide to provide a complete suite of services ranging from fitting out, smart technical support, training, promotion, and post-management. At present, with a number of well-known real estate reached a strategic cooperation, the world has laid out more than 100 franchise stores.

No Panda Culture (Bukongwenhua) is a Shanghai-based entertainment and culture agency.

Withwheat is a bakery chain that focuses on producing high-quality European-style soft bread and a variety of baked goods, including pastries and fruit cakes. The brand is known for its commitment to health-conscious baking, utilizing significantly lower amounts of sugar and oil compared to traditional bread, and avoiding preservatives, trans fats, and artificial flavors. This emphasis on quality and health has resulted in strong consumer demand. Withwheat operates micro shops throughout Beijing, allowing for efficient distribution of its products to a wide audience.

DeePhi Technology Co., Ltd. is a Beijing-based company specializing in deep learning artificial intelligence computing applications. Founded in 2016, it develops solutions that integrate deep compression and a dedicated processing unit (DPU) to optimize performance across a range of devices, from large servers to mobile terminals. The company focuses on improving neural network efficiency through techniques such as compression, pruning, and system-level optimization, facilitating low-power and low-latency AI services. DeePhi's technology is utilized in various sectors, including drone technology, security surveillance, and cloud services. By offering end-to-end solutions, DeePhi aims to enhance the effectiveness and economy of AI inference platforms for both embedded systems and server-side applications. The company operates as a subsidiary of Xilinx, Inc.

Manman is a mobile comics platform established in Beijing in 2017, specializing in the production and distribution of original comic content. With over 980 titles available, including 315 exclusives, the app has cultivated a user base exceeding 14 million, of which 3 million are active users. Notably, 2 million users maintain more than 20 subscriptions, demonstrating a strong engagement with the platform. Manman aims to generate revenue through paid subscriptions, advertising, and reward systems, enhancing the entertainment experience for its audience by providing diverse and novel comic topics.

Beijing GenomePrecision Technology Co., Ltd. is a molecular diagnostic company focused on developing precision medicine tests to enhance the diagnosis and treatment of various diseases, including blood tumors, transplantation needs, and cardiovascular conditions. Established in 2015 and headquartered in Beijing, the company integrates research and development, manufacturing, distribution, and registration of its products. GenomePrecision utilizes advanced molecular technology platforms, such as real-time fluorescence quantitative PCR, Sanger sequencing, high-throughput next-generation sequencing, and capillary electrophoresis, to create a diverse range of diagnostic products. These include tests for leukemia, lymphoma, solid tumors, and pharmacogenomics, as well as tools for organ transplant monitoring and pathogen detection. The company also produces molecular diagnostic kits for targeted drug testing and auxiliary diagnosis of cervical cancer, among other applications. By focusing on clinical diagnosis and treatment requirements, GenomePrecision aims to improve patient outcomes through innovative molecular diagnostics.

Novogene Co., Ltd. is a prominent global provider of genomic services and solutions, specializing in next-generation sequencing (NGS) and bioinformatics. Founded in 2011 and headquartered in Beijing, China, the company offers a wide range of genomic solutions, including human genome sequencing, cancer genomic profiling, and single-cell sequencing, as well as clinical-grade whole exome sequencing services. Novogene also developed innovative products like NovoFocus, a companion diagnostic assay for PARP inhibitor therapies, and NovoNeoantigen, a bioinformatics pipeline for identifying cancer neoantigens. With the largest sequencing capacity in the world and a workforce of approximately 1,800 employees, Novogene has established itself as a leader in the genomics field, holding 49 NGS-related patents and contributing to over 1,850 published customer research papers in prestigious scientific journals. The company’s founder, Dr. Ruiqiang Li, is recognized as an expert in genomics and bioinformatics, having significantly advanced the field through his research and innovative software development.